Feeds:
Posts
Comments

Archive for the ‘New prostate drugs’ Category

PR NEWSWIRE: The launch and uptake of nine emerging therapies will drive the prostate cancer drug market to more than double, from nearly $4 billion in 2009 to $8.4 billion in 2019 in the US, France, Germany, Italy, Spain, the UK and Japan. READ MORE>

Read Full Post »

WALL ST JOURNAL: The US Food and Drug Administration has approved Jevtana, a chemotherapy drug used in combination with the steroid prednisone to treat men with advanced prostate cancer. READ MORE> and HERE>

Read Full Post »

THE GAZETTE: Canadian scientists have developed an experimental new drug to shrink prostate cancer tumours, based on molecules extracted from a marine sponge collected in New Guinea. READ MORE>.

Read Full Post »

NEW PROSTATE CANCER INFOLINK: When it comes to prostate cancer, one of the really key issues taxing the medical oncology community over the past few days has been: “How do we need to start thinking about the future treatment of advanced prostate cancer?” READ MORE>

Mike Scott provides a list of new drugs and treatments that are now approved or in prospect for treating advanced prostate cancer.

Read Full Post »

PHARMACY EUROPE: A new hormone therapy drug for prostate cancer than can be taken once every six months has successfully completed its European registration procedure and will soon be rolled out for use on patients. READ MORE>

Read Full Post »

URO TODAY: Once, chemotherapy (then death) were the only options left for prostate cancer patients on whom hormone therapy stopped working: now new drugs give hope of extended life. READ MORE>

Read Full Post »

MEDICAL NEWS TODAY: A new type of cancer drug called PARP inhibitors – including a new drug called olaparib that is currently showing promising results in trials as a targeted treatment for inherited forms of breast and ovarian cancer - may also be effective against prostate cancer. READ MORE>

Read Full Post »

Older Posts »

Follow

Get every new post delivered to your Inbox.